| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2848990 | American Heart Journal | 2009 | 8 Pages |
Abstract
Angiotensin-converting enzyme inhibition does not significantly modify major biomarkers of inflammation, hemostasis, and endothelial function. Further studies should confirm the possible effect of ACE inhibitors on the fibrinolysis pathway.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Matteo MD, PhD, Stephen B. PhD, Hal H. MD, Brenda W. PhD, Mauro Di MD, PhD, Russell P. PhD, Marco MD,